Understanding how COVID-19 affects patients' financial situations
The cost of illness: The impact of COVID-19 on patient financial outcomes
This study looks at how COVID-19 affects people's finances, especially those who might struggle the most, to understand the real costs and stress that come from being sick during the pandemic.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10903780 on NIH RePORTER |
What this research studies
This research investigates the financial impact of COVID-19 on patients, focusing on how illness can lead to financial burden and distress. The study aims to identify which patient groups are most at risk for financial difficulties after COVID-19 infection and to measure both the objective financial burden and subjective financial distress experienced by these patients. By linking health data with credit report information, the research seeks to provide a clearer picture of the economic consequences of the pandemic on individuals, particularly vulnerable populations.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have been infected with COVID-19, particularly those from vulnerable populations or those experiencing significant financial distress.
Not a fit: Patients who have not been infected with COVID-19 or those who do not experience financial difficulties may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could help inform policies that protect patients from financial harm related to illness.
How similar studies have performed: While the concept of financial toxicity is recognized, this specific approach to linking health outcomes with financial data in the context of COVID-19 is relatively novel and has not been extensively tested.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Becker, Nora V. — University of Michigan at Ann Arbor
- Study coordinator: Becker, Nora V.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.